Paul Mango, deputy chief of staff for policy at US Health and Human Services, said during a briefing on Wednesday it’s an aspiration that no American will have to pay for a Covid-19 vaccine
“In terms of a principle and an aspiration, it’ll be that no American has to pay a single dime out of pocket to get a vaccine,” Mango said. “And we’re getting very close to that aspiration right now.”
Where things stand on vaccine development: The AstraZeneca coronavirus vaccine trial, halted last week after an unexplained illness in one of the volunteers, will resume, the University of Oxford announced Saturday.
The university, which is developing the vaccine with AstraZeneca, did not say when the trial would resume. AstraZeneca said the trial will only resume in the United Kingdom, adding that it's working with health authorities across the world to determine when other trials can resume.
Before the pause, the company was testing its vaccine, dubbed the Oxford vaccine, in the United States as well as in the United Kingdom, Latin America, Asia, Europe and Africa.
The AstraZeneca vaccine is one of three coronavirus vaccines in late-stage, Phase 3 trials in the US. It has the backing of the US federal government. Moderna and Pfizer/BioNTec are the other two groups with phase three trials under way, also with federal government funding.